Marshall Wace’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-900
Closed -$86.5K 3512
2025
Q4
$86.5K Buy
900
+200
+29% +$19.4K ﹤0.01% 2730
2025
Q3
$66.7K Buy
+700
New +$64.3K ﹤0.01% 2699

Other funds holding MDT

Marshall Wace's MDT Position: Q2 2026 in Review

Marshall Wace opened a new position in Medtronic (MDT) in Q2 2026: 182,300 shares worth $14.3M. The stake represents 0.01% of the portfolio and ranks #880 among its holdings. This is a return to the name: Marshall Wace previously reported a position in MDT as recently as Q4 2025.

Marshall Wace first reported a position in MDT in Q1 2014 and has held it in 38 quarters since. The position peaked at $144M in Q2 2022. 2,135 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Marshall Wace held 182,300 shares of Medtronic worth $14.3M as of Q2 2026.
  • Medtronic was a new Marshall Wace position in Q2 2026.
  • Medtronic made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #880 holding.
  • Marshall Wace first reported a position in Medtronic in Q1 2014 and has held it in 38 quarters since.
  • Marshall Wace's Medtronic position peaked at $144M in Q2 2022.
  • 2,135 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.